Most material SEC filings — July 30, 2026

Eurus Aerospace Token I LLC (a Forum Markets entity per Section 14 notice address) agreed to purchase one CFM International CFM56-7B aircraft engine from Aero Engine Solutions, Inc. for $11,650,000. The agreement, dated July 27, 2026, provides for closing by July 30, 2026, with the engine sold as-is, where-is, with all faults. Forum Markets will include Seller as additional insured on aviation liability policies up to $600M combined single limit for two years post-closing.

On July 27, 2026, Avanos Medical, Inc. (market cap ~$565.5M) was acquired by A-AV Holdco I, Inc. The acquisition is financed with a $675M Initial Term Loan, $100M Delayed Draw Term Loan commitment, and $100M Priority Revolving Credit Facility from lenders including Golub Capital, Ally Bank, Guggenheim, Goldman Sachs Private Credit, and Jefferies. The transaction involves a merger of A-AV MergerSub with the target, with Avanos surviving as borrower representative. Total gross financing of ~$875M committed against company size of ~$565.5M.

ICE agreed to acquire MarketAxess Holdings Inc. for $167.00 per share in an all-cash transaction, valuing the company at approximately $5.87 billion in equity consideration (based on 35.19M shares outstanding as of July 27, 2026). The merger agreement was signed July 29, 2026, with ICE using a wholly-owned subsidiary (Igloo Merger Sub II) to merge with MarketAxess, which will become a wholly-owned subsidiary of ICE. The deal requires MarketAxess shareholder approval and regulatory clearances including HSR and FINRA approval.

MarketAxess entered into a definitive merger agreement to be acquired by Intercontinental Exchange, Inc. (ICE). The filing does not disclose the acquisition price, deal terms, or timing. In 2Q26, MarketAxess reported total revenues of $218.4M (flat YoY), diluted EPS of $1.93 ($1.95 ex-notable items), and suspended guidance, conference calls, and monthly volume releases pending deal completion.

On July 24, 2026, Curis Inc. (market cap ~$24.8M) received a notice of delisting or failure to satisfy continued listing standards. The filing reports Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing) but provides no specific details regarding the applicable rule violated, timeline for remediation, or proposed listing transfer.

On July 30, 2026, stockholders of Equitable Holdings (97.24% voting in favor, 85.84% of shares outstanding) and Corebridge Financial (99.96% voting in favor, 82.14% of shares outstanding) approved their previously announced merger. The combined entity will serve >12 million customers, bringing together Equitable's $1.1 trillion AUM/A and Corebridge's $380 billion AUM/A. Closure expected by year-end 2026, subject to regulatory approval; Marc Costantini (Corebridge CEO) will lead combined company with Mark Pearson (Equitable CEO) as Executive Chair.

On July 29, 2026, Genprex received notice of delisting or failure to satisfy continued listing standards (Item 3.01). The filing provides no specific details about the listing violation, remediation timeline, or financial impact. This represents a critical corporate governance event for a $7.5M market-cap company.

Flux Power Holdings, Inc. (market cap ~$19.6M) filed an 8-K on July 30, 2026 reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, effective July 24, 2026. The filing text provided contains only metadata and form structure with no substantive disclosure of the specific listing rule violated, the exchange involved, remediation timeline, or any conditions for reinstatement.

On July 27, 2026, Keen Vision Acquisition Corp. (market cap ~$72.8M) received notice of delisting or failure to satisfy continued listing rules/standards, with a potential transfer of listing. The filing provides no specific details on the underlying cause, remediation timeline, or financial impact. This is a critical corporate governance event for a blank-check company.

Chief Executive Officer Huang Jack Jiajia (COE) bought 637K shares (~$10.7M) on the open market (1.9% of holdings). Open-market insider purchase — historically a bullish signal.

Patrick Industries (NASDAQ: PATK), a $2.9B market-cap component solutions provider, signed a definitive all-stock merger agreement with LCI Industries on June 30, 2026 (announced in this Q2 2026 earnings release dated July 30, 2026). The transaction is all-stock; no counterparty payment amounts or exchange ratio disclosed in this filing. Q2 2026 standalone results show net sales of $1.04B (flat vs. prior year), operating income of $77M (down from $87M), and diluted EPS of $1.28 (up 33% on a reported basis, but down 14% on adjusted basis from $1.50). RV segment revenue declined 15% due to 16% drop in wholesale unit shipments; Marine and Powersports grew 22% and 28% respectively. Free cash flow on trailing twelve-month basis was $128M vs. $262M prior year, reflecting elevated working capital investment in composites. Company returned $106M to shareholders in Q2 (dividends + buybacks). Total debt approximately $1.4B; net leverage 3.0x.

AiRWA Inc. completed acquisition of Hong Kong Best Life Trade Co., Limited on July 30, 2026, paying $30M in USDT upfront for 97% equity stake, with $20M additional base payment due within 90 days plus contingent earn-out tied to revenue milestones. Best Life is an import-export company; the deal expands AiRWA's revenue diversification beyond its core AI business.

On July 30, 2026, stockholders of Corebridge Financial (NYSE: CRBG) and Equitable Holdings (NYSE: EQH) voted to approve their merger. Corebridge shareholders approved the deal with 99.96% voting in favor (82.14% of outstanding shares); Equitable shareholders approved with 97.24% in favor (85.84% of outstanding shares). The combined entity will serve over 12 million customers, control approximately $1.5 trillion in assets under management and administration, and create a leading multichannel platform for retirement and investment solutions. The transaction remains subject to regulatory approval and is expected to close by year-end 2026.

Socket Mobile reported Q2 2026 revenue of $3.0M (down 25% from $4.0M in Q2 2025 and 18% sequentially from Q1 2026), with gross margin declining to 46.4% from 49.9% YoY. Operating loss widened to $1.195M from $677K YoY. Cash balance fell to $1.6M as of June 30, 2026 from $1.7M on March 31, 2026, while subordinated convertible debt (including related-party notes) totals $5.84M. Management attributes results to continued retail market challenges and is implementing cost management initiatives.

New ERA Energy & Digital filed an 8-K on 2026-07-30 reporting Item 4.02 (Non-Reliance on Previously Issued Financial Statements). The filing discloses that previously issued financial statements and/or audit reports can no longer be relied upon. No specific dollar amounts, affected periods, or detailed reasons are disclosed in the header metadata provided.

Columbia Financial completed its second-step conversion offering on July 20, 2026, raising $1.7 billion in gross proceeds, and simultaneously acquired Northfield Bancorp, Inc., adding ~$5.8 billion in total assets. The combined entity will have $18.0 billion in proforma assets as of March 31, 2026, with over 100 branches across New Jersey, Staten Island, and Brooklyn. Q2 2026 standalone results showed net income of $14.5 million ($0.14/share), up 17.7% YoY, driven by net interest margin expansion to 2.44% (up 25 bps YoY) and $260.6 million in commercial loan growth; the company declared a quarterly cash dividend of $0.05/share.

10% owner Catalyst4, Inc. (MLPT) bought 1.2M shares (~$15.3M) on the open market (5.5% of holdings). Open-market insider purchase — historically a bullish signal.

On May 18, 2026, Quince Therapeutics completed acquisition of Orphai Therapeutics for an undisclosed upfront amount. Quince received $115 million gross upfront proceeds in a private placement from a 13-member investor syndicate led by Balyasny, Affinity, Coastlands, and others. Up to $72 million additional warrant exercise proceeds are available, plus $11 million to former Orphai shareholders. LAM-001 (inhaled rapamycin dry powder) is Quince's lead asset: Phase 2a in PH-ILD/PAH completed (10 patients, 6 completed); Phase 2b ongoing in PH-ILD (75 patients, Q1 2028 data); Phase 2 in BOS ongoing (19 patients, fully enrolled, Q1 2027 data); Phase 2 SAPH planned (late 2026, Q4 2028 data). Orphan drug designations granted for BOS, PAH, LAM, sarcoidosis (US) and BOS, LAM (EU).

Darling Ingredients reported Q2 2026 net income of $387.3M ($2.41/share diluted) vs. $12.7M ($0.08/share) in Q2 2025. Combined Adjusted EBITDA surged to $741.7M from $249.5M YoY, driven by Diamond Green Diesel (DGD, 50% owned JV) which generated $389.2M of Darling's share vs. $42.6M prior year. DGD sold 348.8M gallons at $2.23/gallon EBITDA (vs. $0.34 in Q2 2025) due to finalized RVO mandates and improved renewable diesel margins. Company received $280M cash from DGD ($211M dividends, $69M tax credits), reduced net debt by $223M, repurchased $73M stock, and closed Brazil rendering acquisition (~$122M) and grease trap business sale (~$90M).

Mangoceuticals (MGRX, ~$14.7M market cap) is combining with Nuclea Energy, a British Columbia nuclear technology company developing the Morpheus Microreactor. Nuclea shareholders will receive ~96% equity of Mango on a fully diluted basis post-closing via exchangeable shares. A $15M minimum PIPE financing is a closing condition. CEO Jacob D. Cohen will transition to President with $1.5M severance, 2M bonus shares, and a $10M Mango & Peaches warrant. Closing expected before August 21, 2026; Mango stockholder and Nasdaq approvals required post-closing.

Expand Energy Corporation (Buyer) agreed to acquire Twin Eagle Holdings N.A., LLC and its subsidiaries (Acquired Entities) via merger for a Base Purchase Price of $1,250,000,000, with a $62.5M deposit and up to $20M–10% post-closing escrow. Purchase price subject to working capital and debt adjustments. Deal dated July 24, 2026; closing contingent on HSR clearance and regulatory approvals. Buyer will assume ~$500M indebtedness and pay transaction expenses (~50% Buyer/Seller split).

Republic Airways reported Q2 2026 revenues of $571.1M (up 40.8% YoY) and net income of $31.2M ($0.68 per diluted share). The company raised full-year 2026 guidance: revenues from ~$2.0B to ~$2.1B, adjusted EBITDAR from >$380M to $395–$405M, and block hour production from ≥865k to ≥880k hours. Matt Koscal became President & CEO effective June 15, 2026. The Mesa Airlines merger (closed Nov 25, 2025) added 60 E175 aircraft for United Airlines; integration expected to take 18–24 more months.

On June 16, 2026, YUM Brands entered definitive agreements to divest Pizza Hut: LongRange Capital (private equity) will acquire Pizza Hut excluding Mainland China; Yum China will acquire Pizza Hut in Mainland China and remain master franchisee for KFC and Taco Bell there. Pizza Hut Q2 2026 operating profit declined 12% YoY to $70M (27.6% margin vs. 33.5% prior year). The divestiture is structured to maximize shareholder value while tailoring Pizza Hut to distinct markets. Expected close Q3 2026 with $359M net deferred tax benefit recognized upon signing definitive agreements.

Martin Marietta entered a definitive agreement on June 27, 2026, to acquire Lhoist North America (LNA) for approximately $13.5 billion in cash and stock, expected to close H2 2026. The deal combines LNA's 20 lime/mineral quarries and 45 distribution terminals with MLM's aggregates platform. MLM also raised full-year 2026 revenue guidance to $7.2B–$7.4B (from prior range) while reaffirming Adjusted EBITDA guidance of $2.36B–$2.5B; separately identified $350M in annualized cash flow improvements from operational efficiencies and identified $200M+ cash benefits year-to-date.

Pagaya reported Q2 2026 GAAP net income of $45M (up $29M YoY), total revenue of $387M (+19% YoY), network volume of $3.5B (+33% YoY), and adjusted EBITDA of $124M (+43% YoY). The company raised full-year 2026 net income guidance to $155–$180M (from prior implied ~$131M), implying a 4Q26 exit rate exceeding $200M annualized. Auto lending drove 75% of YoY volume growth; company maintained ~1% conversion rate and flat core opex while deploying $3.7B in ABS funding across 6 transactions.

EyePoint announced completion of enrollment in COMO and CAPRI, two global Phase 3 trials of DURAVYU for diabetic macular edema (DME), with over 480 patients enrolled across both trials in five months—ahead of schedule. The trials compare DURAVYU 2.7mg (dosed every six months) to on-label 2mg aflibercept control with non-inferiority primary endpoint on visual acuity at weeks 52/56. Topline data for both DME trials are anticipated in Q4 2027; wet AMD Phase 3 data (LUGANO and LUCIA, with 900+ patients) expected to report beginning August 2026.

Replimune presented to FDA advisory committee on July 30, 2026, seeking accelerated approval of vusolimogene oderparepvec-wtpg (TUDRIQEV/RP1) combined with nivolumab for unresectable advanced cutaneous melanoma in patients with disease progression on anti-PD-1 therapy. The IGNYTE Phase 2 trial (N=140) showed 33.6% ORR (95% CI: 25.8-42%) with median duration of response of 24.8 months; median OS 32.9 months (3-year OS rate 47.8%). Safety profile was manageable with mainly Grade 1-2 adverse events and no treatment-related Grade 5 deaths in the melanoma cohort. FDA clinical reviewers recommended approval on July 15, 2025, noting the 33.6% ORR was substantially higher than the 5-7% expected with further anti-PD-1 monotherapy, and superior to lifileucel (AMTAGVI, 31.5% ORR with 7.5% treatment-related mortality).

First Carolina Financial Services completed its IPO on June 22, 2026, raising net proceeds of $69.3 million after underwriting costs by selling 5,500,000 shares at $12.50/share, plus 825,000 additional shares via underwriter option. Q2 2026 net income was $5.1 million ($0.20 diluted EPS), up 11% YoY; the company achieved a 3.23% net interest margin (18 bps expansion YoY), generated $58.1M loan growth (8.9% annualized), and reduced CDs by 53.5% YoY. Tangible book value per share was $11.66; the company serves 3.4B in assets with operations across Carolinas, Virginia, and Georgia.

Lite Strategy repurchased approximately 4.9 million shares (13% of outstanding) between December 2025 and July 17, 2026, spending $5.4 million at an average price of $1.11 per share. The company funded repurchases entirely from Litecoin sales and covered call premiums without incurring debt. As of July 17, 2026, the company holds 819,070 LTC backing 31.9 million outstanding shares, with the discount to NAV narrowing from 40% to below 25%.

EMCOR reported Q2 2026 revenues of $5.15B (+19.8% YoY), operating income of $547.3M (10.6% margin), and diluted EPS of $9.06 (+34.8% YoY). Record remaining performance obligations reached $17.14B (+43.9% YoY). The company raised full-year 2026 revenue guidance to $20.00–$20.50B (from $18.50–$19.25B) and diluted EPS guidance to $32.00–$33.25 (from $28.25–$29.75).

On July 14, 2026, Catalyst Bancorp (market cap ~$43M) completed acquisition of Lakeside Bancshares and Lakeside Bank. Q2 2026 net income was $524,000 ($0.14 diluted EPS) vs. Q1 $558,000 ($0.15 EPS). Merger-related expenses totaled $87,000 pre-tax in Q2. Post-merger, consolidated equity is estimated at $78.7M (12.5% of assets, down from 28.5% pre-merger). Company repurchased 24,206 shares at $16.20/share. Total assets reached $290.0M at June 30, 2026. Loan portfolio declined 1% to $162.8M; deposits grew 1% to $196.4M; non-performing loans improved to 1.43% of loans.

Lexaria Bioscience (market cap ~$24.6M) will execute a 1-for-15 reverse stock split effective August 3, 2026, consolidating 24,787,446 shares into 1,652,518 shares. The primary goal is to regain NASDAQ compliance with the $1.00 minimum bid price rule (Listing Rule 5550(a)(2)). The company is below the minimum price threshold and faces potential delisting; the reverse split is intended to boost per-share price and stabilize stock conditions to support business development and investor appeal.

On July 16, 2026, Laser Photonics entered a warrant inducement agreement with five holders of Series A-5 and A-6 warrants (exercisable for 2,528,572 shares at $0.975/share). In exchange for cash exercise, the company issued Series A-7 warrants (800,000 shares at $0.975, 5-year term) and Series A-8 warrants (4,257,144 shares at $0.975, 24-month term), plus 234,058 placement agent warrants to H.C. Wainwright. Total: 5,234,144 shares underlying warrants registered for resale. Company received $2,465,357.70 gross proceeds. This is the third consecutive warrant refinancing in six months (prior deals in March and April 2026), each rolling existing warrants into new tranches at lower exercise prices.

Monolithic Power Systems reported Q2 2026 revenue of $980.6M (up 47.6% YoY, 21.9% QoQ), GAAP net income of $257.3M ($5.22 diluted EPS), and non-GAAP net income of $320.1M ($6.50 diluted EPS). Enterprise Data surged 164% YoY to $380.6M (38.8% of revenue). For Q3 2026, MPS forecasts revenue of $1,140–$1,160M and guided gross margin 55.2–55.8% GAAP. Board authorized an additional $500M stock repurchase (total authorization now $1B). Company expanded capacity goal significantly beyond $6B and began sampling 800V data center AC-DC products.

On July 29, 2026, the FDA's Cellular, Tissue and Gene Therapies Advisory Committee voted 9-3 against the effectiveness of Deramiocel (CAP-1002) for treating cardiomyopathy in DMD patients. The vote was non-binding and addressed a narrower indication than Capricor proposed. However, the Committee gave directionally supportive feedback on upper limb function (skeletal muscle) from the Phase 3 HOPE-3 trial. The FDA PDUFA target action date remains August 22, 2026.

PTC reported Q2 2026 total revenue of $361 million ($239M product revenue), with Sephience generating $151M. The company raised full-year 2026 total revenue guidance to $1.18–$1.28 billion (product revenue $850–$950M, up from $750–$850M prior guidance). Key events: $50M milestone payment from Novartis triggered by INVEST-HD Phase 3 initiation; $550M convertible notes issued at 0% coupon; cash position $2.229 billion; 83.3M shares outstanding.

Olin Corporation reported Q2 2026 net loss of $13.3M ($0.12/share) vs. $1.3M loss YoY, with adjusted EBITDA of $191.3M (up 8.7% from $176.1M). On June 16, 2026, Olin entered a definitive all-stock merger agreement with Huntsman Corporation to form OlinHuntsman, expected to close H1 2027, pending regulatory and shareholder approvals. Q2 results were significantly impacted by an unplanned shutdown of the vinyl chloride monomer plant in Freeport, Texas, reducing EBITDA by $40M in Q2 with $20M impact expected in Q3. Olin incurred $10.6M in acquisition-related costs and paid approximately $93M to resolve legacy Shintech litigation.

Cohu reported Q2 2026 net sales of $149.0M (up 38% YoY from $107.7M), with GAAP net loss of $0.2M ($0.00 per share) but non-GAAP net income of $14.1M ($0.26 per share). Test cell utilization improved to 80% sequentially by end-June. Management raised FY2026 AI compute opportunity pipeline estimate to approximately $850M and raised high-performance computing revenue guidance to $100M–$110M. Cash and investments stood at $498.2M; no share repurchases occurred in Q2. Q3 2026 sales guidance: $170M ± $7M.

Grand Canyon Education, Inc. (Provider) and Grand Canyon University (University) executed an Amended and Restated Master Services Agreement effective July 1, 2026, replacing the prior agreement from July 1, 2018. The agreement extends through June 30, 2041 (15 years), with automatic renewal for up to three additional 5-year terms. Provider receives 60% of University Tuition and Fee Revenue for delivering marketing, enrollment, student support, technology platform, financial aid, accounting, HR, and other back-office services. The contract includes exclusivity provisions for designated services, detailed compliance obligations (FERPA, Title IV, HEA Section 495), indemnification terms, and dispute resolution via JAMS mediation/arbitration in Phoenix, Arizona.

Reddit reported Q2 2026 revenue of $805 million (+61% YoY), net income of $253 million (+183% YoY), and Adjusted EBITDA of $343 million (+106% YoY). Daily active uniques reached 130.3 million (+18% YoY); weekly active uniques crossed 514.6 million (+24% YoY). The company repurchased 1.5 million shares for $235 million at $157.57/share. Q3 guidance: revenue $860–870 million, Adjusted EBITDA $385–395 million.

Lakeshore Acquisition III Corp. amended its Investment Management Trust Agreement on July 27, 2026, to permit up to 12 one-month extensions of its business combination deadline from August 1, 2026, to August 1, 2027, at a cost of $67,500 per extension month (total potential $810,000). Shareholders approved the extension at an extraordinary general meeting. The trust account will liquidate and return funds to public shareholders if no business combination closes by August 1, 2027, or if the company elects termination earlier.

Carpenter Technology reported Q4 FY26 operating income of $206.9M (up 37% YoY, 11% vs Q3), with SAO adjusted operating margin reaching record 37.8%. The company generated $362.3M adjusted free cash flow in FY26 and executed $179.1M in share repurchases against a $400M authorization ($281M completed to date). For FY27, management guides operating income of $850–880M (21–25% growth over FY26's $702M), with FY29 target of $1,200–1,300M representing 20–23% three-year CAGR, driven by strong aerospace/defense demand and brownfield capacity expansion commissioning in early FY28.

Carpenter Technology (market cap ~$8.5B) reported FY2026 adjusted operating income of $702.0M (+34% YoY), with Q4 operating income of $206.9M. The Specialty Alloys Operations segment delivered record 37.8% operating margins. The company raised FY2027 guidance to $850–880M operating income (+21–25% YoY) and announced a FY2029 target of $1.2–1.3B. Generated $605M operating cash flow and $362.3M adjusted free cash flow in FY2026; repurchased $179.1M shares against a $400M program.

Annexon Inc. entered into a loan and security agreement with Oxford Finance LLC dated July 30, 2026, for up to $200 million in term loans. The company drew $50 million (Term A Loan) at closing. An additional $100 million becomes available upon achievement of FDA approval milestones for vonaprument (Geographic Atrophy) and tanruprubart (Guillain-Barré Syndrome), with the remaining $50 million (Term E Loan) subject to lender discretion. Interest accrues at 1-Month CME Term SOFR plus 4.60% (floor 7.60%); loans mature July 1, 2031 (or 2032 if extended), with a 1.00% facility fee, prepayment fees of 1–2%, and a final payment tied to loan amount.

MasTec closed the acquisition of The Superior Group (≈3,000 employees, full-service electrical contractor) on July 24, 2026. Q2 2026 revenue was $4.374B (+23% YoY), diluted EPS $1.65 (+51% YoY), adjusted EBITDA $384M (+40% YoY), and 18-month backlog reached record $21.4B (+$4.9B YoY, +30%). FY2026 guidance raised: diluted EPS to $6.20 (+22% YoY), adjusted diluted EPS to $9.30 (+42% YoY); no acquisition price disclosed in this filing.

NCS Multistage (market cap ~$23.9M) reported Q2 2026 revenues of $38.4M (+5% YoY) but net loss of $(4.6)M vs. prior-year income of $0.9M. Cash position weakened to $31.3M (from $36.7M at year-end 2025). Company entered merger agreement with Weatherford International on May 31, 2026; >50% shareholder approval already obtained; deal expected to close H2 2026. Adjusted EBITDA declined to $1.9M from $2.2M YoY. SG&A increased $4.3M primarily due to Weatherford transaction professional fees.

Huntsman reported Q2 2026 net loss of $6M ($0.03/share, vs. $158M loss prior year) and adjusted EBITDA of $120M (vs. $74M). Revenues rose 14% to $1,663M driven by pricing and volume gains across all three segments (Polyurethanes +16%, Advanced Materials +19%). Free cash flow turned negative at -$90M vs. +$55M prior year, reflecting $113M H1 operating cash outflow. The all-stock "merger of equals" with Olin Corporation (announced June 16, 2026) faces stockholder vote August 25, 2026; combined entity targets synergies and vertical integration benefits.

Home Federal Bancorp (Nasdaq: HFBL), a $27.1M market-cap Louisiana bank holding company, reported fiscal year 2026 (ended June 30) net income of $6.174M vs. $3.888M prior year—a 59% increase. Key drivers: net interest income rose $3.118M (16.7%), net interest margin expanded 49 bps to 3.72%, loans grew $14.35M (3.1%), and deposits grew $31M (5.7%). Diluted EPS increased to $2.02 from $1.26; book value per share rose to $19.31 from $17.90. Non-performing assets increased slightly to $3.649M (0.57% of assets) from $3.305M.

Aqua Metals reported Q2 2026 results and announced progression toward Phase 1 commercial operations of its Headwaters ARC facility. The company advanced final site-specific diligence on a ~150,000 sq ft Midwest industrial facility with ~50+ acres, located near six major LFP gigafactory projects, and expects to announce site selection this quarter. Phase 1 will deploy proven mechanical preprocessing equipment to recover copper, aluminum, and black mass from LFP battery materials; Phase 2 will add AquaRefining technology for lithium carbonate, iron phosphate, and graphite recovery. The company reported $4.7M cash (down from $10.8M six months prior), Q2 net loss of $4.5M, and accumulated deficit of $278.9M; it remains debt-free and intends to deploy capital in step with commercial milestones.

North European Oil Royalty Trust announced a Q3 2026 distribution of $0.26 per unit (equal to Q3 2025, but up from Q2 2026's $0.22), payable August 31, 2026 to record owners as of August 17, 2026. The trailing 12-month cumulative distribution is $1.01 per unit, representing a 47.5% increase ($0.49 higher) compared to the prior 12-month period's $0.52 per unit. Distributions are derived from Mobil and OEG royalty agreements, paid on a one-quarter lag basis.